New VP Research Louise Proulx to start April 1
Louise Proulx, until recently a vice-president with Biochem Pharma, has been appointed Vice-Principal (Research) at McGill University, effective April 1.
Louise Proulx, until recently a vice-president with Biochem Pharma, has been appointed Vice-Principal (Research) at McGill University, effective April 1. The appointment, based on the recommendation of a Search Committee which included faculty, students and governors, was approved by the Board of Governors last evening and announced by Principal Bernard Shapiro. Her predecessor, Dr. Pierre Bélanger, is retiring after 35 years as a researcher, teacher and administrator at the University.
"Dr. Proulx's research background and her international contacts will help her to manage in an environment defined by the global acceleration of knowledge," noted Principal Shapiro. "She also possesses excellent negotiating skills, solid experience in managing complex relations with government funding agencies and the private sector, and an entrepreneurial flair for making things happen."
For her part, Dr. Proulx is enthusiastic about working at McGill. "I'm looking forward to returning to academia after 15 years away, and I'm confident that the experience I acquired in the private sector will benefit the University, its researchers and its students," she said.
Louise Proulx received her undergraduate degree from the Université de Sherbrooke and her doctorate from Université Laval, before pursuing postdoctoral studies at the Karolinska Institute in Stockholm. As vice-president at Biochem Pharma both in Quebec and Massachusetts, she greatly expanded the development budget, managed major projects in the field of HIV and cancer, and played a critical role in evaluating new opportunities for research collaboration, product licensing and mergers and acquisitions. Before that, working at Hoechst Marion Roussel Canada, she was responsible for all clinical, biostatistical, project management and regulatory activities in Canada. She also participated in the planning and coordination of all new products at the international level, working with team-members from the U.S., France, the U.K., Italy and Japan. As a researcher, she held grants from the then-Medical Research Council of Canada, the National Cancer Institute, and the Fonds de la recherche en santé du Québec.
A worldwide leader in many areas of research, McGill ranked first in last year's Canada Foundation for Innovation (CFI) grants, with 22 out of its 24 requests funded. Attracting high levels of federal and international support to Quebec, McGill educates more PhDs relative to its number of professors than any other Canadian university and publishes nearly half of all journal articles produced by the Quebec university network. Average research revenue per professor is the highest in Canada, and plans for renewing the academic and physical infrastructure will allow the University to maintain its preeminent role, while building on strong ties with other universities.